[go: up one dir, main page]

AR008295A1 - Celulas inmortalizadas, y metodo para producir y usar dichas celulas para la produccion de virus. - Google Patents

Celulas inmortalizadas, y metodo para producir y usar dichas celulas para la produccion de virus.

Info

Publication number
AR008295A1
AR008295A1 ARP970103697A ARP970103697A AR008295A1 AR 008295 A1 AR008295 A1 AR 008295A1 AR P970103697 A ARP970103697 A AR P970103697A AR P970103697 A ARP970103697 A AR P970103697A AR 008295 A1 AR008295 A1 AR 008295A1
Authority
AR
Argentina
Prior art keywords
cells
immortalized
viruses
producing
production
Prior art date
Application number
ARP970103697A
Other languages
English (en)
Original Assignee
Univ Minnesota
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Minnesota filed Critical Univ Minnesota
Publication of AR008295A1 publication Critical patent/AR008295A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4746Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used p53
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16311Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16351Methods of production or purification of viral material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011Details
    • C12N2720/12011Reoviridae
    • C12N2720/12051Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Método para transformar células de pollo mediante la introducción de un ácido nucleico que codifica p53 bajo el control del promotor de metalotioneinaen céulas primarias para producir líneas de células inmortalizadas. También se refiere amétodo s para propagar virus empleando líneas celulares inmortalizadasy células inmortalizadas
ARP970103697A 1996-08-13 1997-08-13 Celulas inmortalizadas, y metodo para producir y usar dichas celulas para la produccion de virus. AR008295A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/696,376 US5830723A (en) 1996-08-13 1996-08-13 Method for immortalizing chicken cells

Publications (1)

Publication Number Publication Date
AR008295A1 true AR008295A1 (es) 1999-12-29

Family

ID=24796804

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970103697A AR008295A1 (es) 1996-08-13 1997-08-13 Celulas inmortalizadas, y metodo para producir y usar dichas celulas para la produccion de virus.

Country Status (26)

Country Link
US (1) US5830723A (es)
EP (1) EP0956355B1 (es)
JP (1) JP3833714B2 (es)
KR (1) KR100375872B1 (es)
CN (1) CN1133745C (es)
AR (1) AR008295A1 (es)
AT (1) ATE280236T1 (es)
AU (1) AU717693B2 (es)
BR (1) BR9711165B1 (es)
CA (1) CA2263790C (es)
CO (1) CO4650227A1 (es)
DE (1) DE69731310T2 (es)
DZ (1) DZ2292A1 (es)
ES (1) ES2230619T3 (es)
GT (1) GT199700092A (es)
HU (1) HUP9903946A3 (es)
IL (1) IL128512A (es)
MA (1) MA24592A1 (es)
MY (1) MY121698A (es)
NZ (1) NZ334146A (es)
PE (1) PE1899A1 (es)
PT (1) PT956355E (es)
SA (1) SA97180647B1 (es)
UY (1) UY24667A1 (es)
WO (1) WO1998006827A2 (es)
ZA (1) ZA977215B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1161689A1 (en) 1999-03-16 2001-12-12 Serex, Inc. Method and device for detection of apo a, apo b and the ratio thereof in saliva
EP1048724A1 (en) * 1999-04-27 2000-11-02 Transgene S.A. Human myoblast cell lines and their uses
EP1048725B1 (en) * 1999-04-27 2005-07-06 Transgene S.A. Process for production of mammalian cell lines
EP1069187A1 (en) * 1999-07-14 2001-01-17 Stichting Dienst Landbouwkundig Onderzoek Mosaic Infectious Bursal Disease Virus vaccines
FR2836924B1 (fr) 2002-03-08 2005-01-14 Vivalis Lignees de cellules aviaires utiles pour la production de substances d'interet
EP1528101A1 (en) * 2003-11-03 2005-05-04 ProBioGen AG Immortalized avian cell lines for virus production
EP1854455B1 (en) 2006-05-10 2009-10-07 Biocompatibles UK Limited Spherical microcapsules comprising GLP-1 peptides, their production and use
EP2163243A1 (en) 2008-09-12 2010-03-17 Biocompatibles UK Limited Treatment of acute myocardial infarction (AMI) using encapsulated cells encoding and secreting GLP-1 peptides or analogs thereof
EP2251028A1 (en) 2009-05-12 2010-11-17 Biocompatibles Uk Ltd. Treatment of eye diseases using encapsulated cells encoding and secreting an anti-angiogenic factor and/or a neuroprotective factor
US20140004201A1 (en) 2010-09-15 2014-01-02 Biocompatibles Uk Ltd. Treatment of Vascular Diseases Using Encapsulated Cells Encoding and Secreting GLP-1, or a Fragment or Variant Thereof
AU2019270977B2 (en) * 2018-05-14 2025-01-02 Roosterbio, Inc. Methods and compositions related to extracellular material derived from hypertonic cell solutions
CN120137888B (zh) * 2025-05-15 2025-08-05 南京农业大学 一种用于细胞培养肉可长期传代的猪成纤维细胞系及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2634784A1 (fr) * 1988-08-01 1990-02-02 Inst Nat Sante Rech Med Lignees de cellules epitheliales intestinales immortalisees, leurs procedes de preparation et leurs applications en tant que systeme de production de facteurs de croissance et en tant que modele d'etude de la physiopathologie digestive fonctionnelle et cancereuse
DE4142452A1 (de) * 1991-12-18 1993-06-24 Max Planck Gesellschaft Mittel zur stimulierung der teilungsaktivitaet tierischer zellen
WO1995002041A1 (en) * 1993-07-09 1995-01-19 La Jolla Cancer Research Foundation Conditionally immortalized germ cell lines
WO1995031567A1 (en) * 1994-05-17 1995-11-23 Rutgers University Immortalized and transformed astrocyte-derived cells

Also Published As

Publication number Publication date
DE69731310T2 (de) 2006-02-23
SA97180647B1 (ar) 2006-09-05
MA24592A1 (fr) 1999-04-01
MY121698A (en) 2006-02-28
EP0956355A2 (en) 1999-11-17
CO4650227A1 (es) 1998-09-03
US5830723A (en) 1998-11-03
DE69731310D1 (de) 2004-11-25
CA2263790C (en) 2003-10-14
BR9711165B1 (pt) 2008-11-18
PE1899A1 (es) 1999-02-02
JP3833714B2 (ja) 2006-10-18
UY24667A1 (es) 1998-02-02
IL128512A (en) 2005-07-25
HUP9903946A3 (en) 2000-09-28
KR100375872B1 (ko) 2003-03-10
GT199700092A (es) 1997-08-12
PT956355E (pt) 2005-01-31
ATE280236T1 (de) 2004-11-15
ES2230619T3 (es) 2005-05-01
CN1228122A (zh) 1999-09-08
NZ334146A (en) 2001-01-26
CA2263790A1 (en) 1998-02-19
HUP9903946A2 (hu) 2000-03-28
AU717693B2 (en) 2000-03-30
JP2000516469A (ja) 2000-12-12
ZA977215B (en) 1998-02-19
WO1998006827A3 (en) 1998-03-26
BR9711165A (pt) 1999-08-17
KR20000029970A (ko) 2000-05-25
WO1998006827A2 (en) 1998-02-19
HK1022497A1 (en) 2000-08-11
CN1133745C (zh) 2004-01-07
EP0956355B1 (en) 2004-10-20
AU3982997A (en) 1998-03-06
IL128512A0 (en) 2000-01-31
DZ2292A1 (fr) 2002-12-25

Similar Documents

Publication Publication Date Title
AR008295A1 (es) Celulas inmortalizadas, y metodo para producir y usar dichas celulas para la produccion de virus.
BR9106287A (pt) Celula de membrana de prensa de filtro,processo para operar a celula,e processo para producao de acido perciorico
DK0985675T3 (da) Hydrosilaniseringsfremgangsmåde med höjt udbytte
ES8505412A1 (es) Un metodo para producir eficazmente un factor de crecimiento similar a insulina humana
ATE223383T1 (de) Verfahren zur herstellung von 3-haloalkyl-1h- pyrazole
DK0663010T3 (da) Fremgangsmåde til forøgelse af sekretion af overudtrykte proteiner
CO5021164A1 (es) Genes de elongasa y sus usos
DE69832624D1 (de) Hefestämme zur herstellung von milchsäure
DK0864645T3 (da) Negativstrenget RNA-virusvektor med autonom replikeringsaktivitet
ES8708016A1 (es) Un procedimiento para sintetizar una secuencia de aminoacidos que contienen la totalidad o parte de la secuencia de aminoacidos de la preprorrelaxina -h2 humana.
TR199700944T1 (xx) Dimetil eter �retimi ve metanoldan yeniden kazan�m.
ES2009210A6 (es) Un procedimiento para la obtencion de nuevos polipeptidos que proporcionan anticuerpos frente a virus de sida, yno reaccionantes con anticuerpos sida.
BR0206809A (pt) Cepas de leveduras que produzem esteróides de modo autÈnomo
ES2093642T3 (es) Celulas cho que producen gluco-cerebrosidasa re-combinante enzimaticamente activa.
BR8108346A (pt) Processo para preparacao enzimatica de acido l-2-amino-4-metil-fosfinobutirico
ES2139402T3 (es) Un proceso para preparar una fraccion del acido hialuronico con un bajo indice de polidispersion.
TR199901115T2 (xx) Yeni metoprolol �retim i�lemi.
DE3878463D1 (de) Verfahren zur 9-alpha-dehalogenierung von 9-alpha-steroiden.
ES2159296T3 (es) Procedimiento para preparar 2,2-difluorocetena silil acetales y esteres de acido alfa,alfa-difluoro-beta-sililoxi-1,3-dioxolano-4-propanoico.
DE69722195D1 (de) Verfahren zur herstellung von methylmercatopropanal
ATE452180T1 (de) Blakeslea trispora zur herstellung von lycopin in hoher ausbeute, in einem geeigneten medium in abwesenheit eines exogenen corotenogenese- hemmstoffes
ATE335750T1 (de) Verfahren zur herstellung von organosilylalkylpolysulfanen
ES503630A0 (es) Procedimiento para la fabricacion del acido b-hidroxibutiri-co o sus oligocondensados
ATE329050T1 (de) Herstellung von ascorbinsäure unter verwendung von hefe
NO960927L (no) Fremgangsmåte ved fremstilling av 9-(2-hydroksy)-etoksymetylguanin

Legal Events

Date Code Title Description
FG Grant, registration